Cornell researchers David Nanus, Brian Kirby and Evi Giannakakou explain their new microfluidic device that collects circulating, living prostate cancer tumor cells from blood.

The research, conducted collaboratively between Cornell's Ithaca and NYC campuses, aims toward tailoring cancer treatment and improving patient survival.

The June 12, 2012 presentation is part of Inside Cornell series.